rs78433961

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS1

The NM_000208.4(INSR):ā€‹c.2388G>Cā€‹(p.Arg796Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000444 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00034 ( 0 hom., cov: 32)
Exomes š‘“: 0.00045 ( 0 hom. )

Consequence

INSR
NM_000208.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:3

Conservation

PhyloP100: -0.189
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), INSR. . Gene score misZ 3.8314 (greater than the threshold 3.09). Trascript score misZ 5.4593 (greater than threshold 3.09). GenCC has associacion of gene with insulin-resistance syndrome type A, hyperinsulinism due to INSR deficiency, Rabson-Mendenhall syndrome, Donohue syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.037588835).
BP6
Variant 19-7142970-C-G is Benign according to our data. Variant chr19-7142970-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 549552.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=4, Benign=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000342 (52/152174) while in subpopulation NFE AF= 0.000676 (46/68038). AF 95% confidence interval is 0.00052. There are 0 homozygotes in gnomad4. There are 21 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
INSRNM_000208.4 linkuse as main transcriptc.2388G>C p.Arg796Ser missense_variant 12/22 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkuse as main transcriptc.2352G>C p.Arg784Ser missense_variant 11/21 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkuse as main transcriptc.2388G>C p.Arg796Ser missense_variant 12/22 XP_011526290.2
INSRXM_011527989.4 linkuse as main transcriptc.2352G>C p.Arg784Ser missense_variant 11/21 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkuse as main transcriptc.2388G>C p.Arg796Ser missense_variant 12/221 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkuse as main transcriptc.2352G>C p.Arg784Ser missense_variant 11/211 ENSP00000342838.4 P06213-2
INSRENST00000597211.1 linkuse as main transcriptn.71G>C non_coding_transcript_exon_variant 1/23

Frequencies

GnomAD3 genomes
AF:
0.000342
AC:
52
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000676
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000298
AC:
75
AN:
251330
Hom.:
0
AF XY:
0.000243
AC XY:
33
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.000501
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000455
AC:
665
AN:
1461878
Hom.:
0
Cov.:
32
AF XY:
0.000458
AC XY:
333
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000618
Gnomad4 NFE exome
AF:
0.000556
Gnomad4 OTH exome
AF:
0.000232
GnomAD4 genome
AF:
0.000342
AC:
52
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.000283
AC XY:
21
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000282
Gnomad4 NFE
AF:
0.000676
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000745
Hom.:
0
Bravo
AF:
0.000261
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000296
AC:
36
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Leprechaunism syndrome;C0271695:Rabson-Mendenhall syndrome;C0342278:Insulin-resistant diabetes mellitus AND acanthosis nigricans;C1864952:Hyperinsulinism due to INSR deficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 03, 2021The c.2388G>C (p.R796S) alteration is located in exon 12 (coding exon 12) of the INSR gene. This alteration results from a G to C substitution at nucleotide position 2388, causing the arginine (R) at amino acid position 796 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitterresearchPersonalized Diabetes Medicine Program, University of Maryland School of MedicineMar 10, 2017ACMG Criteria:BP4 (9 predictors) -
Leprechaunism syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Insulin-resistant diabetes mellitus AND acanthosis nigricans Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Rabson-Mendenhall syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 20, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
17
DANN
Benign
0.89
DEOGEN2
Uncertain
0.42
.;T
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.92
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.038
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.71
.;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.83
N;N
REVEL
Benign
0.033
Sift
Benign
0.55
T;T
Sift4G
Benign
0.47
T;T
Polyphen
0.031
B;B
Vest4
0.21
MutPred
0.34
.;Gain of phosphorylation at R796 (P = 0.0124);
MVP
0.69
MPC
0.86
ClinPred
0.011
T
GERP RS
-0.36
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.38
gMVP
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs78433961; hg19: chr19-7142981; API